COVID-19 Alert for Cancer Patients

The Vanderbilt-Ingram Cancer Center is following the COVID-19 pandemic closely and taking steps to protect our patients and our staff. Please be assured that we are here for you.

Updated September 11, 2020

VICC COVID-19 Newsletter

We will be diligently updating information on a regular basis for specific diseases and conditions.

For cancer info, click here.
Para más información en Español sobre cáncer visite la siguiente página.

For the latest info about coronavirus for VUMC patients and visitors.

For the latest VUMC restricted visitor policy.

Partners in Discovery

Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.

No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer.

_{Harnessing the power of

science for our patients}

_{Our doctors and researchers are turning today's}
_{scientific discoveries into tomorrow's treatments.}
_{Learn more about our research programs and initiatives.}

Research Programs

Specialized Programs of Research Excellence (SPOREs)

Research Centers & Initiatives

Proven Track Record

A leader in research, innovation and treatment. We are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach.

Patients, Partners, Progress

Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care.

Read their stories from Momentum magazine.

We’ve Only Just Begun

Facing cancer with youthful resilience

Pay it Forward

Bladder cancer research fund honors mentor

Blazing a new trail

Clinical trial participant forges a different treatment path

Vanderbilt mourns the passing of Pierre Massion

Pierre Massion, MD, an internationally known expert on early detection and prevention strategies for lung cancer, died April 4.

Study revises understanding of cancer metabolism

Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit.

Personalized Structural Biology aids cancer treatment decisions

Cancer specialists at VUMC, in partnership with biochemists and structural biologists across the VU campus, are taking “personalized” cancer therapy to a new level.

New Clinician Spotlight: Robert Ramirez

Robert Ramirez, DO, a thoracic and neuroendocrine oncologist, has joined Vanderbilt-Ingram Cancer Center.

COVID-19 and Cancer Consortium study highlights racial disparities, increased mortality for patients facing dual diagnoses

The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.

EGFR Resisters/LUNGevity fund lung cancer research

Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.